Justine Hugon‐rodin - Gynecology

Author Information

Justine Hugon-Rodin is a distinguished researcher affiliated with the Division for Gynaecology and Unit Reproductive Medicine at the Department of Gynaecology and Obstetrics, University Hospitals of Geneva, and the Faculty of Medicine of the Geneva University in Switzerland. Additionally, she is associated with the Department of Gynecology Obstetrics II and Reproductive Medicine at the Centre Hospitalier Universitaire (CHU) Cochin, University Paris Descartes, in Paris, France.

Research Contributions

Justine Hugon-Rodin has made significant contributions to gynecology, particularly in areas such as abnormal uterine bleeding, primary ovarian insufficiency, menopause, and thromboembolic events. Her research often focuses on clinical practice guidelines, offering insights into managing various conditions affecting women's reproductive health. She has also explored the use of next generation sequencing in diagnosing idiopathic primary ovarian insufficiency, emphasizing the importance of advanced genetic techniques in reproductive medicine.

Aliases

Justine Hugon-Rodin is also known by aliases such as J Hugon-rodin and Justine Hugon‒rodin.

Publication and Citation Metrics

Citation Count	690
H-index	16
Paper Count	51

Publications:

[Management of women with abnormal uterine bleeding: clinical practice guidelines of the French National College of Gynecologists and Obstetricians (CNGOF)].

DOI: 10.1016/j.gofs.2022.02.078

Year: 2022

Next Generation Sequencing Should Be Proposed to Every Woman With “Idiopathic” Primary Ovarian Insufficiency

DOI: 10.1210/jendso/bvab032

Year: 2021

[News on progestatives in gynaecology].

DOI:

Year: 2021

NEXT GENERATION SEQUENCING SHOULD BE PROPOSED TO EVERY WOMAN WITH "IDIOPATHIC" PREMATURE OVARIAN INSUFFICIENCY

DOI: 10.1210/JENDSO/BVAB032/6154706

Year: 2021

P–622 Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive techniques

DOI: 10.1093/humrep/deab130.621

Year: 2021

[Menopause and risk of thromboembolic events. CNGOF and GEMVi clinical practice guidelines].

DOI: 10.1016/j.gofs.2021.03.018

Year: 2021

[Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (Short version)].

DOI: 10.1016/j.gofs.2021.03.010

Year: 2021

P-622 Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive techniques

DOI: 10.1093/humrep/deab125.048

Year: 2021

Contraception et maladie thromboembolique veineuse

DOI: 10.53738/revmed.2020.16.718.2383

Year: 2020

[Contraception and venous thromboembolism].

DOI:

Year: 2020

How to Care for a Drainage Bag?

How to Prepare for Prenatal Testing?

What is Preimplantation Genetic Diagnosis (PGD)?

What Foods Support Fertility?

What to Do if You Test Positive?

What is Menopausal Depression?

How is Uterine Evacuation Performed?

How do thyroid disorders influence hair loss?

What Questions Should Patients Ask During Gynecological Appointments?

What Services Do Birthing Centers Offer?

Partnered Content Networks

Relevant Topics